BioSpace News Archive

Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is proud to announce that President and CEO Scott Herskovitz has been elected as an at-large board director of the Bio-Process Systems Alliance (BPSA).

When temperatures drop, many regular activities come to a halt, but the American Red Cross needs your help to stop winter weather from giving hospital patients the cold shoulder.

MedInsight executives announced today the MedInsight Solution has achieved Certified status for information security by HITRUST. HITRUST CSF Certification recognizes that MedInsight, the industry leading healthcare analytics ecosystem from Milliman, adheres to the highest standards for healthcare data security and privacy.

Today, Elektra Labs and Carnegie Mellon University researchers announced collaboration on an innovative IoT labeling system for understanding the data rights and security practices of connected health sensors.

Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced the appointment of Esther Martinborough, Ph.D., to its board of directors, expanding its membership to ten directors.

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today reported that on February 1, 2021,

Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that Pablo J. Cagnoni, M.D., president and chief executive officer, and the executive management team will participate in a fireside chat at the Guggenheim Healthcare Talks | 2021 Oncology Days on February 11, 2021

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointments of Ashwin Gollerkeri, MD, as Senior Vice President, Head of Development, and Kevin Dushney, as Vice President, Information Technology, as well as the promotion of Karen Martin, JD, PhD to Vice President, Head of Legal.

--Transaction supports development of AuraVax’s lead COVID-19 intranasal program, plus other vaccines and therapeutics targeting respiratory diseases--

Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”) today announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19